1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

One Lambda Receives CE Mark Approval for C1qScreen Assay and Launches … – PharmiWeb.com (press release)

November 5, 2013HLA Typingadmin

One Lambda Receives CE Mark Approval for C1qScreen Assay and Launches ...
PharmiWeb.com (press release)
About One Lambda Inc.One Lambda Inc. now part of Thermo Fisher Scientific the world leader in service science is the worldwide leader in HLA typing and antibody detection assays. One Lambda is known for its commitment to quality service and innovation.

Post navigation

← Thermo Fisher Scientific Inc. : One Lambda Receives CE Mark Approval for … – 4-traders (press release) Govt staff to lose 'five star' treatment – Times of India →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos